Resectable Colorectal Carcinoma: Clinical Trials

8 trials for Resectable Colorectal Carcinoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 recruiting, 1 active not recruiting, 1 not yet recruiting, 1 terminated. 4 Not applicable, 3 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Recruiting 3, Active not recruiting 1
Phase 23Not yet recruiting 1, Recruiting 1, Terminated 1
Phase 31Unknown 1

Follow Resectable Colorectal Carcinoma: new trials by email Literature Review of Resectable Colorectal Carcinoma trials Research Report on Resectable Colorectal Carcinoma

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HRX215, A First Generation MKK4 Inhibitor Drug, for the Treatment of Patients With Colorectal Liver Metastasis After Undergoing a Portal Vein Embolization
Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 2Not yet recruitingMayo Clinic802026-12-012026-10-05
Minimal Residual Disease Testing for the Early Detection of Cancer Recurrence in Resectable Stage II-IV Colorectal Cancer Patients
Biospecimen Collection, cfDNA or ctDNA Measurement, Electronic Health Record Review - Resectable Colorectal Carcinoma, Stage II Colorectal Cancer AJCC v8
Not applicableRecruitingCity of Hope Medical Center1502025-08-292026-08-12
Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
Trastuzumab deruxtecan, Durvalumab, Panitumumab - Colorectal Cancer, Resectable Colorectal Carcinoma
Phase 2RecruitingGruppo Oncologico del Nord-Ovest1972023-05-112026-09-11
Acupuncture for the Management of Postoperative Pain in Patients With Pancreatic or Colorectal Cancer Undergoing Surgery
Acupuncture Therapy, Best Practice, Questionnaire Administration - Resectable Colorectal Carcinoma, Resectable Digestive System Carcinoma
Not applicableActive not recruitingM.D. Anderson Cancer Center702020-08-122026-06-12
An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response
Diffusion Weighted Imaging - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Not applicableRecruitingM.D. Anderson Cancer Center702020-08-122026-07-20
Anastomotic Leakage and Value Of Indocyanine Green in Decreasing Leakage Rates
ICG-guided bowel perfusion assessment - Colo-rectal Cancer, Crohn Disease
Phase 3UnknownLeiden University Medical Center9782020-07-012021-01-15
Intravital Microscopy in Human Solid Tumors
Diagnostic Microscopy, Fluorescein Sodium Injection - Solid Tumor, Adult, Clinical Stage IV Gastric Cancer AJCC v8
Not applicableRecruitingMayo Clinic852019-02-282026-06-02
Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery
Chemotherapy, Laboratory Biomarker Analysis, Metastasectomy - Metastatic Colorectal Carcinoma, Metastatic Malignant Neoplasm in the Liver
Phase 2TerminatedM.D. Anderson Cancer Center292016-09-232026-02-17

Narrower conditions

Colorectal Neoplasms (6)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Carcinoma, Hepatocellular (1)  ·  Cholangiocarcinoma (1)  ·  Colonic Neoplasms (1)  ·  Crohn Disease (1)  ·  Pancreatic Neoplasms (1)  ·  Sarcoma (1)  ·  Stomach Neoplasms (1)

Broader conditions

Colonic Diseases (7)  ·  Digestive System Diseases (7)  ·  Digestive System Neoplasms (7)  ·  Gastrointestinal Diseases (7)  ·  Gastrointestinal Neoplasms (7)  ·  Intestinal Diseases (7)  ·  Intestinal Neoplasms (7)  ·  Neoplasms (7)  ·  Neoplasms by Site (7)  ·  Rectal Diseases (6)  ·  Adenocarcinoma (1)  ·  Brain Diseases (1)  ·  Breast Diseases (1)  ·  Carcinoma (1)  ·  Central Nervous System Diseases (1)

Interventions

Specimen Handling (2)  ·  Acupuncture Therapy (1)  ·  Biopsy (1)  ·  Cell-Free Nucleic Acids (1)  ·  Circulating Tumor DNA (1)  ·  Drug Therapy (1)  ·  Embolization, Therapeutic (1)  ·  Fluorescein (1)  ·  Fluoresceins (1)  ·  Hepatectomy (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Metastasectomy (1)  ·  Nivolumab (1)  ·  Panitumumab (1)  ·  Practice Guidelines as Topic (1)

Sponsors

M.D. Anderson Cancer Center (3)  ·  Mayo Clinic (2)  ·  City of Hope Medical Center (1)  ·  Gruppo Oncologico del Nord-Ovest (1)  ·  Leiden University Medical Center (1)

Countries

United States (6)  ·  Italy (1)  ·  Netherlands (1)

Top investigators

Alexander Vahrmeijer, MD, PhD (1)  ·  Emmanuel M Gabriel, M.D., Ph.D. (1)  ·  Filippo Pietrantonio, MD (1)  ·  Lorenzo Cohen (1)  ·  Marwan G Fakih (1)  ·  Priya R Bhosale (1)  ·  Scott L. Nyberg, MD, PhD (1)  ·  Yun S Chun (1)

Results publications

PMID 12001988, PMID 17704903, PMID 19906081, PMID 19917863, PMID 20061178, PMID 20233873, PMID 20336386, PMID 20374484, PMID 20490982, PMID 20737573, PMID 21153378, PMID 21909917, PMID 21926464, PMID 22162570, PMID 23456602, PMID 24956510, PMID 25013744, PMID 26883450, PMID 2801858, PMID 33654117, PMID 35365509, PMID 37124504, PMID 3808620, PMID 39151436

NIH funding

P30CA033572 (1), R01DK140085 (1)